The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
There are other, more important factors than 3D beam positioning when treating a cancer patient. The Accuray system has quite a low output and is limited to one energy. This means that treatment times are MUCH longer (up to 10x). This means that the patient throughput is much lower than with a Varian accelerator = loss of income. It also means that the patient has to lie on the table for a much longer time and that is VERY uncomfortable even for a healthy person!
Accuray is typically used for stereotactic radiosurgery which takes a long time anyway. It definitely has its merits but yeah not a lot of versatiliy. What possible advantage is there to acquiring tomotherapy?